Stay for BioDelivery in MonoSol thin-film patents dispute
This article was originally published in Scrip
Executive Summary
BioDelivery Sciences has succeeded in getting a temporary halt to its legal proceedings with MonoSol Rx, while the US Patent and Trademark Office re-examines the patents at the heart of the two companies' battle.